Robots in the Radiopharmaceutical Laboratory…Will They Replace the Chemist?

Over the past decade, numerous devices have been described for the remote synthesis of compounds labelled with radionuclides. The impetus for the construction of these devices was primarily one of safety: the reduction of radiation dose to personnel responsible for the production of these compounds. Other reasons for devoting time and labor into the manufacture of these apparatus were more of a practical nature: reducing operator error and allowing radiochemists to make more efficient use of their time. In the field of Positron Emission Tomography (PET), apparatus that has been constructed for the remote synthesis of positron emitting radiopharmaceuticals has ranged from the manual operation of remote devices (via electrically or pneumatically-operated valves and switches) to computer-controlled devices which operate continuously without operator intervention.1–8 The complexity of these devices depended on the needs of the facility in order to safely provide routine doses of the desired radiopharmaceuticals. Factors affecting apparatus design were the amount of feedback incorporated into the device, the number of manipulations performed by the apparatus, whether the device was intended to be used for other radiopharmaceutical syntheses, and finally, the amount of operator interaction with the device.

[1]  A. Wolf,et al.  A shielded synthesis system for production of 2-deoxy-2-[18F]fluoro-D-glucose. , 1981, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  M. Welch,et al.  Application of robotics to radiopharmaceutical preparation: controlled synthesis of fluorine-18 16 alpha-fluoroestradiol-17 beta. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  C. Dence,et al.  Robotic production of 2-deoxy-2-[18F]fluoro-D-glucose: a routine method of synthesis using tetrabutylammonium [18F]fluoride. , 1988, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

[4]  J. Barrio,et al.  The Unit Operations Approach to the Applied to the Synthesis of [1-11C]2-Deoxy-d-Glucose for Routine Clinical Applications , 1982 .

[5]  G. D. Fiore,et al.  Automated preparation of carbon-11 ethanol and carbon-11 butanol for human studies using positron emission tomography , 1986 .

[6]  R. Iwata,et al.  Automated synthesis system for production of 2-deoxy-2-[18F]fluoro-D-glucose with computer control , 1984 .

[7]  G. Slegers,et al.  Fully automatic, microprocessor-controlled system for the production of 11CO2, 11CH3I and 11C-labeled radiopharmaceuticals. , 1985, The International journal of applied radiation and isotopes.

[8]  C. Dence,et al.  Remote system for production of carbon‐11 labeled palmitic acid , 1983 .

[9]  N Satyamurthy,et al.  Computer-controlled radiochemical synthesis: a chemistry process control unit for the automated production of radiochemicals. , 1989, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

[10]  M J Welch,et al.  Automated production of several positron-emitting radiopharmaceuticals using a single laboratory robot. , 1988, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

[11]  P. H. Cox,et al.  Report of an International Atomic Energy Agency's Advisory Group meeting on "Quality control of cyclotron-produced radiopharmaceuticals". , 1990, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[12]  K. Hamacher,et al.  Computer-aided synthesis (CAS) of no-carrier-added 2-[18F]fluoro-2-deoxy-D-glucose: an efficient automated system for the aminopolyether-supported nucleophilic fluorination , 1990 .